Synopsys, Inc. $SNPS Stock: Jackson Square Capital LLC Reduces Stake

Jackson Square Capital LLC reduced its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 77.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 591 shares of the semiconductor company’s stock after selling 1,994 shares during the quarter. Jackson Square Capital LLC’s holdings in Synopsys were worth $257,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of SNPS. Kaufman Rossin Wealth LLC purchased a new position in shares of Synopsys in the third quarter worth $326,000. Frank Rimerman Advisors LLC boosted its position in shares of Synopsys by 2.4% during the third quarter. Frank Rimerman Advisors LLC now owns 2,549 shares of the semiconductor company’s stock worth $1,109,000 after acquiring an additional 59 shares during the last quarter. Kintegral Advisory LLC boosted its position in shares of Synopsys by 0.6% during the third quarter. Kintegral Advisory LLC now owns 5,812 shares of the semiconductor company’s stock worth $2,528,000 after acquiring an additional 32 shares during the last quarter. Avail Investment Partners LLC boosted its position in shares of Synopsys by 24.4% during the third quarter. Avail Investment Partners LLC now owns 683 shares of the semiconductor company’s stock worth $297,000 after acquiring an additional 134 shares during the last quarter. Finally, Wealth Intelligence LLC grew its stake in Synopsys by 4.0% during the third quarter. Wealth Intelligence LLC now owns 1,175 shares of the semiconductor company’s stock valued at $511,000 after acquiring an additional 45 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.

Synopsys Price Performance

Shares of NASDAQ SNPS traded up $3.93 during midday trading on Monday, reaching $458.56. 1,145,909 shares of the stock traded hands, compared to its average volume of 2,053,737. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The stock has a market capitalization of $87.88 billion, a PE ratio of 81.06, a P/E/G ratio of 1.85 and a beta of 1.21. Synopsys, Inc. has a one year low of $362.55 and a one year high of $539.48. The company’s 50 day moving average is $427.56 and its 200 day moving average is $441.93.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. During the same period last year, the firm posted $3.39 earnings per share. Synopsys’s revenue for the quarter was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities research analysts anticipate that Synopsys, Inc. will post 10.97 earnings per share for the current year.

Synopsys announced that its board has initiated a stock buyback program on Monday, October 5th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of analysts have issued reports on SNPS shares. Piper Sandler upgraded shares of Synopsys from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. Robert W. Baird upgraded shares of Synopsys from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $558.00 to $560.00 in a research note on Thursday, August 27th. Weiss Ratings downgraded shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, September 11th. Wells Fargo & Company raised their price objective on Synopsys from $475.00 to $540.00 and gave the company an “overweight” rating in a research report on Thursday, October 1st. Finally, Barclays started coverage on Synopsys in a research report on Friday, September 25th. They set an “overweight” rating for the company. One analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $571.78.

Insider Buying and Selling at Synopsys

In other Synopsys news, insider Aart de Geus sold 25,000 shares of the stock in a transaction on Monday, August 31st. The shares were sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the completion of the transaction, the insider owned 120,421 shares in the company, valued at $53,197,180.96. This trade represents a 17.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,604 shares of Synopsys stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the completion of the transaction, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at $28,815,151.20. The trade was a 15.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 117,163 shares of company stock worth $51,366,457 over the last three months. 0.56% of the stock is owned by company insiders.

About Synopsys

Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.

The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.

In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.